Breaking
RAPS Euro Convergence: Top Regulatory Insights - Day 1European Research Revolution: Day 1 HighlightsRAPS Euro Convergence: Key Regulatory Updates - Day 1
🌏 NMPA

Securities Fraud

Page 1 • 1 item

Analyze pharma securities fraud trends. NovaPharmaNews provides critical intelligence for investors, analysts, and legal teams navigating regulatory risks.

Soleno Therapeutics Faces Securities Fraud Lawsuit Over Alleged Sham Phase 3 Clinical Trials
NewsUnknownApr 29, 2026

Soleno Therapeutics Faces Securities Fraud Lawsuit Over Alleged Sham Phase 3 Clinical Trials

Soleno Therapeutics hit with securities fraud allegations claiming company conducted fraudulent Phase 3 trials that led to FDA drug approval.

Arjun Menon